| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
22,900,000 |
| Market
Cap: |
35.04(M) |
| Last
Volume: |
145,865 |
Avg
Vol: |
145,469 |
| 52
Week Range: |
$1.17 - $3.61 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Computer Hardware |
| Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile iCAD is a medical technology company providing cancer detection and therapy solutions. Co.'s segments are: Cancer Detection, which includes image analysis and workflow solutions that enable healthcare personnel to identify pathologies and pinpoint prevalent cancers earlier, and various Artificial Intelligence and Computer-Aided Detection systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography; and Cancer Therapy, which provides the Xoft Axxent Electronic Brachytherapy System, an isotope-free cancer treatment platform technology for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
38,960 |
| Total Sell Value |
$0 |
$0 |
$0 |
$106,653 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ferry Kenneth M |
CEO |
• – – |
2018-03-30 |
4 |
A |
$3.08 |
$269,500 |
D/D |
87,500 |
481,636 |
|
- |
|
| Christopher Richard |
CFO, EVP |
• – – |
2018-03-30 |
4 |
D |
$3.08 |
$20,744 |
D/D |
(6,735) |
122,763 |
|
- |
|
| Christopher Richard |
CFO, EVP |
• – – |
2018-03-30 |
4 |
A |
$3.08 |
$179,666 |
D/D |
58,333 |
129,498 |
|
- |
|
| Stevens Stacey M |
Sr VP of Marketing & Strategy |
• – – |
2018-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
154,496 |
|
- |
|
| Christopher Richard |
CFO, EVP |
• – – |
2018-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
71,165 |
|
- |
|
| Ferry Kenneth M |
CEO |
• – – |
2018-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
394,136 |
|
- |
|
| Goodman Robert L |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
14,000 |
|
- |
|
| Subramaniam Somu |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
17,665 |
|
- |
|
| Brem Rachel |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
29,581 |
|
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
492,983 |
|
- |
|
| Ecock Anthony F |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
25,358 |
|
- |
|
| Sassine Andy |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
1,266,714 |
|
- |
|
| Rappaport Steven N |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
81,870 |
|
- |
|
| Sussman Elliot J Md Mba |
Director |
– • – |
2018-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
100,808 |
|
- |
|
| Sassine Andy |
Director |
– • – |
2017-12-29 |
4 |
A |
$3.44 |
$8,751 |
D/D |
2,544 |
1,262,714 |
|
- |
|
| Christopher Richard |
CFO, EVP |
• – – |
2017-12-05 |
4 |
D |
$3.52 |
$19,040 |
D/D |
(5,409) |
46,165 |
|
- |
|
| Ecock Anthony F |
Director |
– • – |
2017-10-20 |
4 |
OE |
$2.00 |
$1,500 |
D/D |
750 |
21,358 |
|
- |
|
| Stevens Stacey M |
Sr. VP of Marketing & Strategy |
• – – |
2017-10-18 |
4 |
D |
$4.59 |
$18,622 |
D/D |
(4,057) |
126,996 |
|
- |
|
| Sussman Elliot J Md Mba |
Director |
– • – |
2017-10-06 |
4 |
OE |
$2.00 |
$20,606 |
D/D |
10,303 |
96,808 |
|
- |
|
| Sassine Andy |
Director |
– • – |
2017-09-29 |
4 |
A |
$4.42 |
$8,752 |
D/D |
1,980 |
1,260,170 |
|
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2017-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
961 |
488,983 |
|
- |
|
| Howard Dr Lawrence |
Director |
– • – |
2017-08-23 |
4 |
B |
$3.33 |
$33,300 |
D/D |
10,000 |
488,022 |
2.39 |
- |
|
| Ecock Anthony F |
Director |
– • – |
2017-07-13 |
4 |
OE |
$2.00 |
$1,500 |
D/D |
750 |
20,608 |
|
- |
|
| Sassine Andy |
Director |
– • – |
2017-06-30 |
4 |
A |
$4.19 |
$8,749 |
D/D |
2,088 |
1,258,190 |
|
- |
|
| Stevens Stacey M |
SVP Marketing & Strategy |
• – – |
2017-06-19 |
4 |
D |
$4.19 |
$9,063 |
D/D |
(2,163) |
131,053 |
|
- |
|
205 Records found
|
|
Page 4 of 9 |
|
|
0.02 (1.32%) 
